etouffoir

  https://articles.mercola.com/sites/articles/archive/2026/10/06/ticagrelor-brilinta-fda-approval-flawed-studies.aspx français https://etouffoir-blogspot-com.translate.goog/2026/10/un-medicament-anticoagulant-succes.html?_x_tr_sl=hl&_x_tr_tl=fr&_x_tr_hl=fr Analysis by Dr. Joseph Mercola  6 octobre 2026 https://www.youtube.com/watch?v=zWbOYoL4RJM Story at-a-glance Ticagrelor, a blockbuster anticlotting drug, was approved despite FDA scientists warning it looked less safe and effective than older, cheaper alternatives like clopidogrel The landmark PLATO trial used to secure approval showed U.S. patients had worse outcomes on ticagrelor, yet those results were overridden by FDA leadership An investigation by The BMJ revealed serious problems with the trial, including altered death records, missing data, and inconsistent monitoring that favored ticagrelor Follow-up platelet studies were also misreported, with non-significant results published as signific...